Patients' and caregivers' experiences of using continuous glucose monitoring to support diabetes self-management: qualitative study
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Continuous glucose monitoring (CGM) enables users to view real-time interstitial glucose readings and provides information on the direction and rate of change of blood glucose levels. Users can also access historical data to inform treatment decisions. While the clinical and psychological benefits of CGM are well established, little is known about how individuals use CGM to inform diabetes self-management. We explored participants' experiences of using CGM in order to provide recommendations for supporting individuals to make optimal use of this technology. METHODS: In-depth interviews (n = 24) with adults, adolescents and parents who had used CGM for ≥4 weeks; data were analysed thematically. RESULTS: Participants found CGM an empowering tool because they could access blood glucose data effortlessly, and trend arrows enabled them to see whether blood glucose was rising or dropping and at what speed. This predicative information aided short-term lifestyle planning and enabled individuals to take action to prevent hypoglycaemia and hyperglycaemia. Having easy access to blood glucose data on a continuous basis also allowed participants to develop a better understanding of how insulin, activity and food impacted on blood glucose. This understanding was described as motivating individuals to make dietary changes and break cycles of over-treating hypoglycaemia and hyperglycaemia. Participants also described how historical CGM data provided a more nuanced picture of blood glucose control than was possible with blood glucose self-monitoring and, hence, better information to inform changes to background insulin doses and mealtime ratios. However, while participants expressed confidence making immediate adjustments to insulin and lifestyle to address impending hypoglycaemia and hypoglycaemia, most described needing and expecting health professionals to interpret historical CGM data and determine changes to background insulin doses and mealtime ratios. While alarms could reinforce a sense of hypoglycaemic safety, some individuals expressed ambivalent views, especially those who perceived alarms as signalling personal failure to achieve optimal glycaemic control. CONCLUSIONS: CGM can be an empowering and motivational tool which enables participants to fine-tune and optimize their blood glucose control. However, individuals may benefit from psycho-social education, training and/or technological support to make optimal use of CGM data and use alarms appropriately.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, too many alarms can produce disappointment, especially for users with sub-optimal self-management behaviors and/or a high HbA1c. They remind these patients of their diabetes diagnosis and imply a personal failure to achieve optimal blood glucose control [ 25 ].”
From Can Glucose Alarm Fatigue Threaten the Absolute Clinical Benefit of Continuous Glucose Monitoring in Optimal Glucose Management in Children and Adolescents with Type 1 Diabetes? A Narrative Review (2025) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Continuous glucose monitoring enables patients with diabetes to view real-time interstitial glucose readings and provides information on the direction and rate of change of blood glucose levels (27)”
From Artificial Intelligence in Medicine: Today and Tomorrow (2020) · cites this paper as [27]
The cited source says what the claim attributes to it.
In the citing paper
“participants, while expressing confidence in the notifications, also declared feelings of personal failure to regulate glucose level (27).”
From Artificial Intelligence in Medicine: Today and Tomorrow (2020) · cites this paper as [27]
The cited source says what the claim attributes to it.
In the citing paper
“Continuous blood glucose monitoring can enable patients to optimize their blood glucose control and reduce stigma associated with hypoglycemic episodes; however, a study focusing on patient experience with glucose monitoring reported that participants, while expressing confidence in the notifications, also declared feelings of personal failure to regulate glucose level (27).”
From Artificial Intelligence in Medicine: Today and Tomorrow (2020) · cites this paper as [27]
In the citing paper
“Parents and young people report protection against hypoglycemic episodes as the primary cause of such feelings [ 25 ]”
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Discovery of Grounded Theory: Strategies for Qualitative Research
Glaser, B. G., & Strauss, A. L. (2017) · Aldine (Routledge reprint) · doi:10.4324/9780203793206 · Cited by 25,789
The Discovery of Grounded Theory
Glaser, B. G., & Strauss, A. L. (2017) · The Discovery of Grounded Theory · doi:10.4324/9780203793206-1 · Cited by 8,344 · cited 1×
“general principles of Grounded Theory research [21].”
Pope, C., & Mays, N. (1995) · BMJ · doi:10.1136/bmj.311.6996.42 · Cited by 2,336
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185
Pickup, J. C., Freeman, S. C., & Sutton, A. J. (2011) · BMJ · doi:10.1136/bmj.d3805 · Cited by 541 · cited 3×
“been shown to reduce hypoglycaemia and hyperglycaemia [2, 3, 5], severe hypoglycaemia [6]; and, improve treatment satisfaction [7–9] and quality of life outcomes [10, 11].”
BackgroundResultthe SWITCH Study Group, Battelino, T., Conget, I., Olsen, B., Schütz-Fuhrmann, I., Hommel, E., Hoogma, R., Schierloh, U., Sulli, N., & Bolinder, J. (2012) · Diabetologia · doi:10.1007/s00125-012-2708-9 · Cited by 494 · cited 2×
“been shown to reduce hypoglycaemia and hyperglycaemia [2, 3, 5], severe hypoglycaemia [6]; and, improve treatment satisfaction [7–9] and quality of life outcomes [10, 11].”
BackgroundLy, T. T., Nicholas, J. A., Retterath, A., Lim, E. M., Davis, E. A., & Jones, T. W. (2013) · JAMA · doi:10.1001/jama.2013.277818 · Cited by 411 · cited 2×
“been shown to reduce hypoglycaemia and hyperglycaemia [2, 3, 5], severe hypoglycaemia [6]; and, improve treatment satisfaction [7–9] and quality of life outcomes [10, 11].”
Backgroundvan Beers, C. A. J., DeVries, J. H., Kleijer, S. J., Smits, M. M., Geelhoed-Duijvestijn, P. H., Kramer, M. H. H., Diamant, M., Snoek, F. J., & Serné, E. H. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30193-0 · Cited by 386 · cited 1×
“been shown to reduce hypoglycaemia and hyperglycaemia [2, 3, 5], severe hypoglycaemia [6]; and, improve treatment satisfaction [7–9] and quality of life outcomes [10, 11].”
BackgroundReal-time continuous glucose monitoring among participants in the T1D Exchange clinic registry
Wong, J. C., Foster, N. C., Maahs, D. M., Raghinaru, D., Bergenstal, R. M., Ahmann, A. J., Peters, A. L., Bode, B. W., Aleppo, G., Hirsch, I. B., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0303 · Cited by 318
Pickup, J. C., Ford Holloway, M., & Samsi, K. (2015) · Diabetes Care · doi:10.2337/dc14-1855 · Cited by 189
Doing health, doing gender: teenagers, diabetes and asthma
Williams, C. (2000) · Social Science & Medicine · doi:10.1016/s0277-9536(99)00340-8 · Cited by 173 · cited 1×
“The decision to interview parents/caregivers of those aged ≤12 years and those aged 13–15 years was made because, in younger groups, parents take responsibility for most diabetes management tasks [18], while supporting and sharing responsibility with adolescents [19].”
BackgroundBarnard, K. D., Wysocki, T., Allen, J. M., Elleri, D., Thabit, H., Leelarathna, L., Gulati, A., Nodale, M., Dunger, D. B., Tinati, T., et al. (2014) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2014-000025 · Cited by 159 · cited 2×
“These included calibration issues, equipment failure and problems inserting and/or removing the device [30].”
BackgroundResultSelf-citation“Turn it Off!”: Diabetes Device Alarm Fatigue Considerations for the Present and the Future
Shivers, J. P., Mackowiak, L., Anhalt, H., & Zisser, H. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700324 · Cited by 158 · cited 1×
“This is an issue which could be explored further in psychological work, to help determine whether some individuals, especially those with sub-optimal selfmanagement behaviours and/or a high HbA1c, would benefit from psychosocial support prior to initiation of CGM to help maximise the benefits from alarms while prevent…”
BackgroundSatisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes
Tansey, M., Laffel, L., Cheng, J., Beck, R., Coffey, J., Huang, E., Kollman, C., Lawrence, J., Lee, J., Ruedy, K., et al. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03368.x · Cited by 125 · cited 1×
“In keeping with findings from previous studies [8, 13, 14, 16] participants reported various glitches and frustrations arising from using CGM.”
ResultPolonsky, W. H., & Hessler, D. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0298 · Cited by 116 · cited 5×
“’s [11] observation that there are notable differences in usability, reliability and performance of CGM devices.”
BackgroundResultInfluentialThe SWITCH Study Group, Hommel, E., Olsen, B., Battelino, T., Conget, I., Schütz-Fuhrmann, I., Hoogma, R., Schierloh, U., Sulli, N., Gough, H., et al. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0598-7 · Cited by 107
Quality-of-Life Measures in Children and Adults With Type 1 Diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010) · Diabetes Care · doi:10.2337/dc10-0331 · Cited by 101
Psychosocial factors associated with use of continuous glucose monitoring
Ritholz, M. D., Atakov‐Castillo, A., Beste, M., Beverly, E. A., Leighton, A., Weinger, K., & Wolpert, H. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03061.x · Cited by 88 · cited 4×
“Like others, [11, 14] our sample, which was recruited from a clinical trial, was heavily skewed towards well-educated/ professional individuals, some of whom who had participated in earlier studies/trials of CGM.”
MethodResultInfluentialLawton, J., Waugh, N. R., Barnard, K. D., Noyes, K., Harden, J., Stephen, J., McDowell, J. R., & Rankin, D. (2014) · Diabetic Medicine · doi:10.1111/dme.12660 · Cited by 85 · cited 1×
“The decision to interview parents/caregivers of those aged ≤12 years and those aged 13–15 years was made because, in younger groups, parents take responsibility for most diabetes management tasks [18], while supporting and sharing responsibility with adolescents [19].”
BackgroundSelf-citationReddy, M., Pesl, P., Xenou, M., Toumazou, C., Johnston, D., Georgiou, P., Herrero, P., & Oliver, N. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0413 · Cited by 70 · cited 1×
“Another alternative may be to consider use of an individualised decision support system exploiting cloud-based technologies with or without health care professional input [28, 29].”
BackgroundPettus, J., Price, D. A., & Edelman, S. V. (2015) · Endocrine Practice · doi:10.4158/ep14520.or · Cited by 69 · cited 1×
“Such observations also help explain clinical research and trial findings that CGM can reduce hypo and hyperglycaemic excursions [2, 3, 5] and amplify and support findings of survey research undertaken with CGM users [22].”
Routine use of continuous glucose monitoring in 10 501 people with diabetes mellitus
Battelino, T., Liabat, S., Veeze, H. J., Castañeda, J., Arrieta, A., & Cohen, O. (2015) · Diabetic Medicine · doi:10.1111/dme.12825 · Cited by 57 · cited 1×
“Indeed, in keeping with observations and recommendations made by others [2, 11, 24] our findings point to a need for psycho-education and training amongst those using CGM to make optimal use of this technology.”
ResultRashotte, J., Tousignant, K. F., Richardson, C., Fothergill‐Bourbonnais, F., Nakhla, M. M., Olivier, P., & Lawson, M. L. (2014) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.02.002 · Cited by 50 · cited 1×
“This includes work exploring barriers to using, and reasons for discontinuing, CGM in adolescent [12] and adult groups [13]; adult users’ attitudes and characteristics which might help predict effective use of CGM [14]; and, how use of CGMmay influence couple’s diabetes management and marital relationships [15].”
MethodHalford, J., & Harris, C. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0121 · Cited by 47 · cited 1×
“been shown to reduce hypoglycaemia and hyperglycaemia [2, 3, 5], severe hypoglycaemia [6]; and, improve treatment satisfaction [7–9] and quality of life outcomes [10, 11].”
BackgroundLawton, J., Rankin, D., Cooke, D. D., Elliott, J., Amiel, S. A., & Heller, S. R. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.09.024 · Cited by 47 · cited 2×
“The potential use of technologies, such as pattern recognition software, could also be considered [25]; indeed, such a recommendation was made by some of those who took part in this study.”
BackgroundMethodSelf-citationTwo concepts of therapeutic optimism
Jansen, L. A. (2011) · Journal of Medical Ethics · doi:10.1136/jme.2010.038943 · Cited by 46 · cited 1×
“In addition, some participants’ earlier experiences of using CGM, and of seeing the technology improve over time, may have resulted in a form of ‘therapeutic optimism’ [32].”
BackgroundJames, S., Perry, L., Gallagher, R., & Lowe, J. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816660326 · Cited by 44
Limitations of Continuous Glucose Monitor Usage
Anhalt, H. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0011 · Cited by 39 · cited 1×
“using CGM for a limited number of weeks and it is possible that participants might have experienced fatigue had they used CGM for longer due to frustrations arising from alarms and CGM systems prompting action as soon as blood glucose moves out of predefined ranges [33, 34].”
MethodRitholz, M. D., Beste, M., Edwards, S. S., Beverly, E. A., Atakov‐Castillo, A., & Wolpert, H. A. (2014) · Diabetic Medicine · doi:10.1111/dme.12276 · Cited by 37
Lawton, J., Kirkham, J., Rankin, D., Barnard, K., Cooper, C. L., Taylor, C., Heller, S., & Elliott, J. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.09.011 · Cited by 30 · cited 1×
“[14] have noted, we would recommend preparation and follow-up training about retrospective data use and analysis be given to individuals using CGM, a training need which has also been identified in other patient groups using flexible intensive insulin regimens [25, 26].”
MethodSelf-citationPsychosocial Factors and Adherence to Continuous Glucose Monitoring in Type 1 Diabetes
Schmidt, S., Duun‐Henriksen, A. K., & Nørgaard, K. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600434 · Cited by 23 · cited 4×
“This includes work exploring barriers to using, and reasons for discontinuing, CGM in adolescent [12] and adult groups [13]; adult users’ attitudes and characteristics which might help predict effective use of CGM [14]; and, how use of CGMmay influence couple’s diabetes management and marital relationships [15].”
BackgroundMethodResultInfluentialBally, L., Thabit, H., Tauschmann, M., Allen, J. M., Hartnell, S., Wilinska, M. E., Exall, J., Huegel, V., Sibayan, J., Borgman, S. K., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016738 · Cited by 17
Self-citationContinuous Glucose Monitoring in 2014
Bode, B. W., & Battelino, T. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.1502 · Cited by 10
Continuous Glucose Monitoring in 2013
Battelino, T., & Bode, B. W. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.1502 · Cited by 7
Cited by
Artificial Intelligence in Medicine: Today and Tomorrow
Briganti, G., & Le Moine, O. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00027 · Cited by 743
“…monitoring enables patients with diabetes to view real-time interstitial glucose readings and provides information on the direction and rate of change of blood glucose levels (27) Medtronic received FDA approval for their Guardian system for glucose monitoring, which is smartphone-paired (28).”
Grunberger, G., Sherr, J., Allende, M., Blevins, T., Bode, B., Handelsman, Y., Hellman, R., Lajara, R., Roberts, V. L., Rodbard, D., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.008 · Cited by 288
de Wit, M., Gajewska, K. A., Goethals, E. R., McDarby, V., Zhao, X., Hapunda, G., Delamater, A. M., & DiMeglio, L. A. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13428 · Cited by 185
McCall, A. L., Lieb, D. C., Gianchandani, R., MacMaster, H., Maynard, G. A., Murad, M. H., Seaquist, E., Wolfsdorf, J. I., Wright, R. F., & Wiercioch, W. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac596 · Cited by 123
Patient-generated health data management and quality challenges in remote patient monitoring
Abdolkhani, R., Gray, K., Borda, A., & DeSouza, R. (2019) · JAMIA Open · doi:10.1093/jamiaopen/ooz036 · Cited by 127
Metadata
- Authors
- Lawton, J., Blackburn, M., Allen, J., Campbell, F., Elleri, D., Leelarathna, L., Rankin, D., Tauschmann, M., Thabit, H., & Hovorka, R.
- Affiliations
- University of Edinburgh (GB)
- University of Cambridge (GB)
- Leeds Teaching Hospitals NHS Trust (GB)
- Royal Hospital for Sick Children (GB)
- Manchester Academic Health Science Centre (GB)
- Corresponding author
- Lawton, J.
- Venue
- BMC Endocrine Disorders
- Published
- 2018-02-20
- Volume
- 18
- Issue
- 1
- Pages
- 12-12
- ISSN
- 1472-6823 (ISSN-L)
- PMC
- PMC5819241
- OpenAlex
- W2791784198
- Cited by
- 174
- References
- 34
- Citations by year
- 2026: 15 · 2025: 30 · 2024: 21 · 2023: 22 · 2022: 26 · 2021: 24 · 2020: 20 · 2019: 13 · 2018: 2
- FWCI
- 11.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- BMC Endocrine Disorders (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research Explorer (The University of Manchester) (submittedVersion, cc-by)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo
- Apollo (cc-by)
- Funders
- JDRF
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Keywords
- continuous glucose monitoring, diabetes self-management, patient experience, caregiver experiences, hypoglycemia, hyperglycemia, insulin dose adjustment, glycemic control, empowerment, adolescents, parents
- MeSH terms
- Self-Management, Adolescent, Adult, Aged, Diabetes Mellitus, Type 1, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Hyperglycemia, Hypoglycemia, Male, Middle Aged, Parents, Quality of Life, Blood Glucose Self-Monitoring, Caregivers, Qualitative Research, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.